PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2012

Feb 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (NONE)
CIK: 0001401667
Period of Report: 2012-02-13

Reporting Person: Malley Thomas (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-13	Stock Option (Right to Buy)	$3.75	A	30000	Acquired	2022-02-13	Common Stock (30000)	Direct
2012-02-13	Stock Option (Right to Buy)	$3.75	A	20000	Acquired	2022-02-13	Common Stock (20000)	Direct

Footnotes

F1: The vesting commencement date ("Vesting Commencement Date) of the option is October 4, 2011. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer.

F2: The vesting commencement date ("Vesting Commencement Date) of the option is February 13, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service through each vesting date as chair of the Audit Committee of the Board of Directors of the Issuer.